Recon: Japan approves Lilly’s Alzheimer’s drug; MHRA seeks applicants for AI Airlock
ReconJason Scott
Approval/marketing authorizationArtificial intelligence/machine learning (AI/ML)Biologics/ biosimilars/ vaccinesEuropeGlobalMedical DevicesNorth AmericaPharmaceuticalsPharmaceuticals and Medical Devices Agency (PMDA)Regulatory Intelligence/PolicyUnited States